WO1987002267A1 - Blood serum test strip - Google Patents
Blood serum test strip Download PDFInfo
- Publication number
- WO1987002267A1 WO1987002267A1 PCT/US1986/002192 US8602192W WO8702267A1 WO 1987002267 A1 WO1987002267 A1 WO 1987002267A1 US 8602192 W US8602192 W US 8602192W WO 8702267 A1 WO8702267 A1 WO 8702267A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- semipermeable membrane
- reactive
- surfactant
- components
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
- C12Q2326/10—Benzidines
- C12Q2326/12—3,3',5,5'-Tetramethylbenzidine, i.e. TMB
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Definitions
- the present invention relates generally to diagnostic devices and techniques and more particularly to arrangements for testing the blood of humans or other animals to determine the concentration of selected plasma components.
- Test strips or sticks which are to be immersed in or subjected to a sample and which include an indicato.r which changes color in response to the presence of a particular substance in the sample are old and well known, including, for example, the familiar litmus or other indicator papers for determining the pH or hydrogen ion concentration of solutions as well as other somewhat more sophisticated test devices for detecting clinically significant substances in biological fluids such as glucose or protein in blood or urine samples.
- 3,3',5,5'tetramethylbenzidine as an indicator material which exhibits a color change in response to an enzyme catalyzed reaction.
- These commonly owned patented schemes are concerned with testing a wide variety of body fluids for cholesterol, glucose and other materials, and include the suggestion of peroxidase and peroxidase-like substances as catalysts in promoting the color change reaction on the indicator. Many of the techniques disclosed in these patents are limited to laboratory environments.
- 3,092,465 co-invented by one of the co-inventors herein employs a double enzyme reaction for determining the concentration of glucose in blood.
- a drop of blood is placed on a semipermeable membrane and after a specified time interval the surface of that membrane is wiped or washed to remove the cellular and particulate blood components that did not pass through the semipermeable membrane so that the reaction induced by the glucose which did pass through the membrane may be observed through the membrane.
- Tests employing this patented arrangement yield 'fairly accurate results, however, the degree of washing or wiping and thus the degree to which the colored blood stains are removed from the membrane, may have a significant effect on the color interpretation of the test results.
- the blood serum or plasma contacts different portions of the enzyme treated reactive area at different times due to the mechanical distributing of the serum both through the semipermeable membrane and spreading laterally, thus producing color variations within the reactive area.
- the color comparison one is not sure whether the central portion of the reactive area or the periphery should be compared to the standard color chart.
- a blood serum test strip of enhanced reliability the provision of a blood testing strip wherein the cellular and particulate blood components are initially blocked and subsequently stripped away allowing unimpeded visual inspection of a reactive area; the provision of a blood testing strip wherein a multiplicity of serum components may be simultaneously concentration tested; the provision of a unique semipermeable membrane arrangement for separating plasma components from whole blood for testing purposes; the provision of a disposable blood component level measuring arrangement with enhanced spreading and metering of the blood sample; and overall improvements in blood component concentration testing techniques.
- Membranes described in patent 3,092,465 become a permanent part of the reactive pad. The thinness and/or permanence of these membranes do not facilitate removal of the membrane; therefor, they must be washed or wiped.
- expanded p ⁇ lytetrafluoroethylene (PTFE) and the spun bonded polyester have the strength to allow them to be pulled away from the reactive pad while retaining the thinness necessary to allow efficient passage of analytes.
- the present invention of stripping away the membrane along with cellular and particulate components facilitates an accurate timing and thus leads to more accurate and reproducible values.
- a process of testing whole blood for certain plasma component concentrations includes the superimposition of a semipermeable membrane and a blood plasma component reactive area and the subsequent subjecting of the semipermeable membrane to a whole blood sample so that plasma components pass through the membrane and onto the reactive area while cellular and particulate components are blocked by the membrane. Thereafter, separation of the membrane fron-jt the reactive area allows measurement of the extent of a plasma component induced change in the reactive area.
- a blood component level determination stick has a supporting matrix, a reactive pad and a hydrophobic semipermeable membrane with hydrophilic pores formed of an expanded polytetrafluoroethylene material. This material is normally hydrophobic and its pores are made hydrophilic by treatment with a surfactant.
- a process according to the present invention includes the separating of analyte components from particulate and/or cellular components using a matrix of pliable hydrophobic interconnecting fibrils which are sufficiently thin to allow the passage of the analyte with the material having a pore size to keep particulate and/or cellular components from passing through when the material has been treated with a surfactant.
- the process includes the subsequent step of removing the matrix so that the particle free analyte can be processed or a reaction caused by it can be directly viewed.
- a disposable blood component level measuring arrangement has a blood level component reactive area and an overlay which is permeable by the blood plasma or serum components and impermeable by blood cellular components.
- the overlay is superposed over the reactive area to receive the blood sample and subsequently separable therefrom to expose the reactive area for visual inspection.
- the overlay is formed of a hydrophobic material which has been treated with a surfactant to make its pores hydrophilic and a further overlay also surfactant treated may be employed to more uniformly distribute the blood sample to the reactive area.
- Fig. 1 is a simplified partially schematic view of apparatus for fabricating test strips in accordance with the present invention
- Fig. 2 is an exploded edge view of a test strip manufactured in accordance with the techniques of the present invention
- Fig. 3 is a plan view of partially completed test strips in accordance with the present invention.
- Fig. 4 is a plan view of a completed test strip
- Fig. 5 is a view in cross-section along lines 5-5 of Fig. 3;
- Figs. 6a through 6e illustrate in exaggerated form a portion of a test strip and migration of a blood sample therein;
- Fig. 7 is a perspective view of the test strip of Fig. 4 during use.
- Fig. 8 is a view similar to Fig. 7 but illustrating a multiple component test strip in use.
- the product which is the object of the manufacturing portion of the present invention has a carrier matrix 30 impregnated with a composition of matter thereby forming a reactive pad 31 for performing the desired testing function.
- Reactive pad 31 is bonded to a support strip 11 such as a polyester or other paper or plastic material which is inert as far as any reactions are concerned and functions simply as a means for manipulating the reactive pad 31.
- Strip 11 may, for example, be on the order of 3 inches (7.62 cm.) in length and 3/16ths of an inch (0.47625 cm.) in width and of any convenient thickness such as five to ten thousandths of an inch (0.0127 to 0.0254 cm.).
- the carrier matrix forming the reactive pad may be of any of a wide variety of materials as, for example, suggested in the aforementioned United States patent 4,362,697. Simple chemical filter paper has been successfully used.
- the reactive pad 31 is covered by a semipermeable membrane 13 and by a further overlay 21 with the overlay 21 and semipermeable membrane 13 being stripped off or torn away during use of the test stick.
- the reactive pad 31 and strip 11 are fabricated somewhat in accordance with the aforementioned United States Application Serial Number 703,335 as depicted in the lower portion of Fig. 1.
- a roll source of filter paper 30 is illustrated at 15 and will ultimately be the source of the source of the reactive pads 31.
- a two stage dipping process at 17 and 19 is employed to appropriately impregnate the carrier matrix or filter paper. However, this impregnation may in some cases be accomplished by a single dipping step.
- the strip of filter paper is passed through the bath or dip 17 to impregnate the filter paper with certain of the components of the present inventive composition ⁇ f matter and, subsequent to that dipping, the filter paper strip is dried at 23 by a stream of hot air.
- the strip may pass over a series of driven and idle rollers such as 25 and 27 so as to execute a lengthy circuitous path through a comparatively tall oven through which hot air is passed as indicated by the arrows 33 and 35. Thereafter, the strip passes around further rollers such as 34 and 37 and through a second dip process 19 to absorb additional composition of matter components.
- the strip is then subjected to a second tunnel drying operation 43, similar to 23 at the output of which the strip now carries in a dry state all of the components required of the reactive pad.
- This dried pad is now adhered to the support strip by a pair of pinch rollers 49 and 51.
- the support material may come from roll 45 and receive an adhesive coating at 47 preparatory to being squeezed with the reactive pad by the pinch rollers.
- the first overlay 13 of Figs. 2, 6 and 7 is a semipermeable membrane to be superposed over the blood plasma component reactive area 31.
- This semipermeable membrane may, for example, be of a naturally hydrophobic material treated to make the pores hydrophilic by a surfactant.
- An expanded polytetrafluoroethylene material such as Gore-Tex, available from W. L.
- this semipermeable membrane material 39 is in Fig. 1 fed through a dip of a surfactant or soap-like material which functions generally as a wetting agent to convert the pores of the naturally hydrophobic material to hydrophilic ones. Subsequent to the dip 41, strip 13 may be air dried or passed through a tunnel dryer 53, similar to dryer 23.
- a further overlay 21 which is a polyester, cellulose or similar material sheet and which functions to distribute or spread and meter a blood sample is supplied from roll 53 and passed through a surfactant bath 55 and then air dried or dried in a still further tunnel dryer 57.
- the composite sheets 73 and 75 are further joined passing through pinch rollers 48 and 77 providing the overall composite ribbon at 79 in the form depicted in Fig. 3.
- Subsequent cutters 61 and 59 sever sheet 79 into individual test strips 63, for example, as illustrated in Figs. 4 and 7. Such severing by the cutters 59 and 61 of course occurs along dotted lines such as 81 and 83 in Fig. 3. Also preferably an edge of strip 29 is folded under as illustrated at 85 to facilitate a user subsequently removing strip 29 and those overlays adhering thereto.
- Strip 29 may be double stranded or otherwise perforated so as to also provide a tip strip 87 which may be desirable in some versions ⁇ f the present invention.
- Figs. 6, 7 and 8 The process of testing whole blood to determine the concentration of certain plasma components thereof is illustrated in Figs. 6, 7 and 8.
- the superposed semipermeable membrane 13 and blood plasma component reactive area 31 are subjected to a whole blood sample in the form of blood drop 89 applied thereto as in Fig. 6a.
- Overlay 21, having been treated by a surfactant in bath 55 absorbs and distributes blood sample 89 so that the sample rapidly spreads throughout the width and length of the overlay above the reactive area 31 very rapidly, as illustrated in Figs. 6a and 6b.
- plasma components 90 of the sample pass through the semipermeable membrane 13 while that membrane blocks the cellular and particulate blood components.
- plasma is uniformly presented to the reactive area 31 as illustrated in the transition between Figs. 6b and 6c.
- the user grasps support sheet 11 and the folded over tab 85 tearing the component level determination stick apart, as illustrated in Figs. 6c, 7 and 8, removing semipermeable membrane 13 and the cellular and particulate blood components trapped thereby and clearly exposing the reactive area 31 for visual inspection such as color comparison to a standardized color chart. Any of several other colorimetry techniques such as use of a densitometer or reflectometer may also be employed.
- PTFE Polytetrafluoroethylene
- Gore-Tex A 3 micron pore size expanded Polytetrafluoroethylene (PTFE) membrane (Gore-Tex) was dipped into a 1% Triton X-67 (Alkyl polyether alcohol) in isopropyl alcohol and air dried.
- Triton X-67 Alkyl polyether alcohol
- a polyester sheet such as Hollytex 3257 or a cellulose acetate sheet such as a Celanese development product or cellulose sheet such as Kimwipes was dipped into the 1% Triton X-67 and air dried.
- the assembly of the blood glucose stick is shown in Fig. 2.
- a drop of blood is placed on the overlay shown in Fig. 6a.
- the blood rapidly spreads throughout the overlay 21.
- the glucose, water and other components from the blood are transferred through the membrane 13 to the reactive pad 31.
- the membrane and overlay are stripped off, carrying the blood stain away and leaving a blue color proportional to the blood glucose level on the pad.
- Example II Same as Example I, but omitting the overlay.
- the blood is placed directly on the membrane.
- the surfactant is 5% Triton X-67 in isopropyl alcohol.
- the surfactant may range up to 50% .
- the surfactant may be Tween 80 (Polysorbate 80), BRIJ 35 (Polyoxyethylene 23-Laur ⁇ l Ethyr), IGEPAL CO-630 (nonylphenoxypoly(9) ethyleneoxy ethanol), IGEPAL CO-710 ( nonylphenoxypoly ( 10-11) ethyleneoxy ethanol), EMULPHOGENE DA 630 ( poly (6) oxyethylated decyl alcohol), ANTAROX BL 236 (modified linear aliphatic polyether), RENEX 698 (nonylphenoxyl poly(9)eth ⁇ leneoxy ethanol), Triton X-100, Triton X-45 (Isooctyl phenyl poly(5) ethoxy ethanol), or other nonionic surfactants.
- Tween 80 Polysorbate 80
- BRIJ 35 Polyoxyethylene 23-Laur ⁇ l Ethyr
- IGEPAL CO-630 nonylphenoxypoly(9) ethyleneoxy ethanol
- surfactant may be lauryl sulfates, Tergitol (Sodium tetradecyl sulfate), GAFAC RA600 or GAFAC RE610 (aliphatic polyethyleneoxy phosphate esters), soap or any other anionic surfactant.
- surfactant may be a cationic one, such as HYAMINE 1622 (Paradiisobutyl phenoxy ethyl dimethyl benzyl ammonium chloride).
- surfactant may be an amphoteric one such as 20NYL FSK (modified linear aliphatic polyethoxy dimethyl ammonium acetic acid).
- surfactant may be chosen from the fluorosurfactants known as ZONYL FSN, FSK, FSO, and UR (i.e., polytetrafluoroethylene polyethoxy ethanol)
- Filter paper strips were impregnated with the mix and dried in a tunnel dryer.
- the impregnated strips were dipped in this mix and dried in a tunnel dryer.
- the strips were mounted on polyester backing with transfer tape.
- the impregnated strips were dipped into the mix and dried in a tunnel dryer.
- a drop of blood is placed on the overlay. After 2 minutes, the overlay together with the membrane is stripped off leaving a blue color proportional to the total cholesterol level of the blood.
- Strips are dipped in the mix and dried in a tunnel dryer.
- the membranes of the previous examples are applied.
- a drop of blood is placed on the stick, a yellow to orange to red color develops proportional to the urea level of the blood.
- the membrane is nitrocellulose supported on a thin open weave polyester material.
- the membrane is cellulose acetate supported on a thin open weave polyester material.
- the membrane is ethylcellulose supported on a thin open weave polyester material.
- EXAMPLE LIV For any of the sticks cited in Examples I-L, the membrane is regenerated cellulose supported on a thin open weave polyester material.
- EXAMPLE LV a calcium ion pad is prepared from the calcium indicator o-cresolphthalein complexone, a buffer of pH 10-12 and 8-hydroxyquinoline. The pad is covered with the treated membrane and overlay of the previously described examples.
- a drop of blood is placed on the overlay shown in Fig. 6a.
- the blood rapidly spreads throughout the overlay 21.
- the glucose, water and other components from the blood are transferred through the membrane 13 to the unreactive pad 31.
- the membrane and overlay are stripped off, carrying the blood stain away and leaving the transferred components in this pad.
- the pad end of the stick was immersed in a Trinder reagent for measuring glucose.
- the stick and reagent were incubated for 20 minutes. This reagent was read spectrophotometrically at 505 nm against a blank reagent, and the difference in absorbance proportional to the blood glucose level was noted.
- Example X Same as Example X, but a surfactant of 1% ZONYL FSN in isopropyl alcohol is applied to the filter paper pad.
- a tablet was made by mixing plaster of paris and water to form a working paste. The paste was applied to a polyester backing strip and allowed to air dry at room temperature.
- a drop of blood is placed on the overlay shown in Fig. 6a.
- the blood rapidly spreads throughout the overlay 21.
- the glucose, water and other components from the blood are transferred through the membrane 13 to the unreactive tablet.
- a suitable time such as 2 to 3 minutes, the membrane and overlay are stripped off, carrying the blood stain away and leaving the transferred components in the tablet.
- the tablet end of the stick was immersed in a Trinder reagent for measuring glucose and stirred until the tablet was dissolved.
- the reagent was incubated at room temperature for twenty minutes, allowing the plaster of paris to precipitate and the reaction to go to completion.
- the clear reagent was read spectrophotometrically at 505 nm against a blank reagent and the difference in absorbance proportional to the blood glucose level was noted.
- Polyester backing as in several previous examples
- the dried overlay attached to label stock to form a window.
- the membrane element was applied so the membrane window was over each pad. After each pad was covered, the overlay element was also put so that the overlay window was over the pad. A tab was then attached so that the two elements could be pulled from the polyester backing and the reactive pad. Whole blood was applied to each pad overlay and two minutes were allowed to elapse and the two element assembly was removed by use of the tab. Color development in relation to concentration of analyte was observed on each pad.
- Example II Same as Example I, but the membrane is a spun bonded polyester material (Filtration Services Hollytex 3252) and was rubbed on both sides with Triton X-67 surfactant and pressed to obtain the original material thickness.
- the membrane is a spun bonded polyester material (Filtration Services Hollytex 3252) and was rubbed on both sides with Triton X-67 surfactant and pressed to obtain the original material thickness.
- Example LX Same as Example LX, but the surfactant is ZONYL YR.
- FIG. 1 illustrates techniques for forming a blood component level determination stick having a supporting strip 11, a reactive pad 31 and a hydrophobic semipermeable membrane 13 with hydrophilic pores formed, for example, of an expanded polytetrafluoroethylene material and suitable for testing for a wide variety of blood plasma components.
- a single disposable blood component level measuring arrangement may, as illustrated in Fig 8, be employed to test for more than one plasma component at a time.
- the supporting strip 11 has a reactive pad 31 treated in accordance with one of the forgoing examples while reactive pad 91 is treated in accordance with a different one of the forgoing examples, thus giving rise to a disposable blood component level measuring arrangement wherein the reactive area comprises a plurality of discrete subareas each having a different chemical composition and reacting with different blood plasma components.
- the overlay 13 in Fig. 8 is as heretofore described impermeable by blood cellular components and superposed over the reactive area initially to receive a blood sample and subsequently separable therefrom to expose the several reactive areas 31 and 91 for inspection.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT86906634T ATE80564T1 (en) | 1985-10-18 | 1986-10-16 | TEST TAPE FOR BLOOD SERUM. |
DE8686906634T DE3686767T2 (en) | 1985-10-18 | 1986-10-16 | TEST TAPE FOR BLOOD SERUM. |
JP61505556A JPH0743374B2 (en) | 1985-10-18 | 1986-10-16 | Whole blood test method |
SU874203103A RU1838782C (en) | 1985-10-18 | 1987-06-17 | Method of plasma separation from blood cellular components |
NO872565A NO872565L (en) | 1985-10-18 | 1987-06-18 | BLOOD ROOM PRESTRIMP. |
DK311187A DK166171C (en) | 1985-10-18 | 1987-06-18 | PROCEDURES FOR ANALYTICAL ANALYSIS AND TEST SHEET FOR USE |
FI872741A FI89108C (en) | 1985-10-18 | 1987-06-18 | Testing procedure for whole blood measuring device for measuring the concentration of a blood component |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US788,793 | 1985-10-18 | ||
US06/788,793 US4839296A (en) | 1985-10-18 | 1985-10-18 | Blood plasma test method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1987002267A1 true WO1987002267A1 (en) | 1987-04-23 |
Family
ID=25145572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1986/002192 WO1987002267A1 (en) | 1985-10-18 | 1986-10-16 | Blood serum test strip |
Country Status (12)
Country | Link |
---|---|
US (2) | US4839296A (en) |
EP (1) | EP0248037B1 (en) |
JP (1) | JPH0743374B2 (en) |
AT (1) | ATE80564T1 (en) |
AU (1) | AU594389B2 (en) |
CA (1) | CA1296976C (en) |
DE (1) | DE3686767T2 (en) |
DK (1) | DK166171C (en) |
FI (1) | FI89108C (en) |
NO (1) | NO872565L (en) |
RU (1) | RU1838782C (en) |
WO (1) | WO1987002267A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0436897A2 (en) * | 1990-01-12 | 1991-07-17 | Miles Inc. | Device and method of separating and assaying whole blood |
EP0524596A1 (en) * | 1991-07-22 | 1993-01-27 | Fuji Photo Film Co., Ltd. | Method of measuring analyte using dry analytical element |
EP0535485A1 (en) * | 1991-10-03 | 1993-04-07 | Bayer Corporation | Improved device and method of separating and assaying whole blood |
GB2285951A (en) * | 1994-01-21 | 1995-08-02 | Robert Gittins | Semi-permeable membrane |
EP0785012A1 (en) | 1996-01-19 | 1997-07-23 | Fuji Photo Film Co., Ltd. | Blood filter unit |
EP0785430A1 (en) | 1996-01-19 | 1997-07-23 | Fuji Photo Film Co., Ltd. | Separation of plasma or serum sample from whole blood |
WO1998001753A1 (en) * | 1996-07-05 | 1998-01-15 | Amrad Operations Pty. Limited | Blood separation module |
US5996811A (en) * | 1997-02-13 | 1999-12-07 | Fuji Photo Film Co. Ltd. | Plasma collecting device |
ITMI20101730A1 (en) * | 2010-09-23 | 2012-03-24 | Fond Italiana Fegato Onlus | "POINT OF CARE" TYPE SYSTEM OF MEASURING TOTAL BILIRUBIN IN PLASMA, PARTICULARLY OF BABIES |
US11278219B2 (en) * | 2017-09-29 | 2022-03-22 | W. L. Gore & Associates, Inc. | Fluid handling detectors |
US11697279B2 (en) | 2013-06-10 | 2023-07-11 | Roche Diagnostics Operations, Inc. | Method and device for producing a test element |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
CA1310905C (en) * | 1987-06-19 | 1992-12-01 | Marvin A. Genshaw | Process and device for separating and testing whole blood |
JPH0286822A (en) * | 1988-05-02 | 1990-03-27 | Terumo Corp | Hydrophilic porous membrane, production thereof and liquid filter using the same membrane |
US5068195A (en) * | 1988-11-02 | 1991-11-26 | Du Pont Merck Pharmaceutical Company | Dot matrix membrane cell expansion and maintenance vessel |
US5139946A (en) * | 1988-11-02 | 1992-08-18 | Du Pont Merck Pharmaceutical Company | Dot matrix membrane cell expansion |
US5110724A (en) * | 1990-04-02 | 1992-05-05 | Cholestech Corporation | Multi-analyte assay device |
US5166051A (en) * | 1990-08-08 | 1992-11-24 | Genesis Labs, Inc. | Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes |
US5686315A (en) * | 1991-06-14 | 1997-11-11 | Quidel Corporation | Assay device for one step detection of analyte |
JPH05188053A (en) * | 1992-01-10 | 1993-07-27 | Sanwa Kagaku Kenkyusho Co Ltd | Instrument for separating serum or plasma component from blood |
ES2151902T3 (en) * | 1992-03-10 | 2001-01-16 | Quidel Corp | MEANS OF SEPARATION OF RED BALLOONS TO DOSAGE THEM BY SPECIFIC UNION. |
US5858793A (en) * | 1992-11-05 | 1999-01-12 | Hampshire Advisory And Technical Services Limited | Sterile or specific pathogen free environment products |
DE4243995C2 (en) * | 1992-12-23 | 1996-07-25 | Gore W L & Ass Gmbh | Permanent hydrophilic modification for fluoropolymers and methods for generating the modification |
US5652148A (en) * | 1993-04-20 | 1997-07-29 | Actimed Laboratories, Inc. | Method and apparatus for red blood cell separation |
US5766552A (en) * | 1993-04-20 | 1998-06-16 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
US5660798A (en) * | 1993-04-20 | 1997-08-26 | Actimed Laboratories, Inc. | Apparatus for red blood cell separation |
US6096269A (en) * | 1993-08-05 | 2000-08-01 | Charlton; Steven C. | Analyte detection device and process |
US5916521A (en) * | 1995-01-04 | 1999-06-29 | Spectral Diagnostics, Inc. | Lateral flow filter devices for separation of body fluids from particulate materials |
US20020010406A1 (en) | 1996-05-17 | 2002-01-24 | Douglas Joel S. | Methods and apparatus for expressing body fluid from an incision |
EP1579814A3 (en) | 1996-05-17 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
WO1998010283A1 (en) * | 1996-09-05 | 1998-03-12 | Srl, Inc. | Sample protective container integral with body fluid separating sheet |
US5834626A (en) * | 1996-11-29 | 1998-11-10 | De Castro; Emory S. | Colorimetric indicators for breath, air, gas and vapor analyses and method of manufacture |
US5710372A (en) * | 1996-12-17 | 1998-01-20 | Cincinnati Milacron Inc. | Method of analysis for aqueous fluids |
SE9700384D0 (en) * | 1997-02-04 | 1997-02-04 | Biacore Ab | Analytical method and apparatus |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US6862465B2 (en) * | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US5948695A (en) * | 1997-06-17 | 1999-09-07 | Mercury Diagnostics, Inc. | Device for determination of an analyte in a body fluid |
US5968746A (en) * | 1997-11-26 | 1999-10-19 | Schneider; David R. | Method and apparatus for preserving human saliva for testing |
US7384396B2 (en) * | 1998-07-21 | 2008-06-10 | Spectrx Inc. | System and method for continuous analyte monitoring |
JP2004510453A (en) | 1998-07-21 | 2004-04-08 | スペクトルクス,インコーポレイティド | Systems and methods for continuous analyte monitoring |
US6512580B1 (en) | 1999-10-27 | 2003-01-28 | Verification Technologies, Inc. | Method and apparatus for portable product authentication |
US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
DE10119036C1 (en) * | 2001-04-18 | 2002-12-12 | Disetronic Licensing Ag | Immersion sensor for measuring the concentration of an analyte using an oxidase |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US6884592B2 (en) * | 2001-09-05 | 2005-04-26 | Lifescan, Inc. | Devices for analyte concentration determination and methods of manufacturing and using the same |
US6889468B2 (en) * | 2001-12-28 | 2005-05-10 | 3M Innovative Properties Company | Modular systems and methods for using sample processing devices |
DE10204606C1 (en) * | 2002-01-18 | 2003-10-16 | Cholestech Corp | Device and method for high density lipoproteins |
US8858434B2 (en) | 2004-07-13 | 2014-10-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
DE60207196T2 (en) * | 2002-04-09 | 2006-07-20 | Cholestech Corp., Hayward | Method and apparatus for quantification of high density lipoprotein cholesterol |
US7611670B2 (en) * | 2002-04-23 | 2009-11-03 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
US7569184B2 (en) * | 2002-04-23 | 2009-08-04 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
CA2488933C (en) * | 2002-04-23 | 2016-11-01 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
JP4283512B2 (en) * | 2002-09-09 | 2009-06-24 | アークレイ株式会社 | Test tool and method of manufacturing the same |
US20040087874A1 (en) * | 2002-10-28 | 2004-05-06 | David Schneider | Saliva collection system |
DE10252223A1 (en) * | 2002-11-11 | 2004-05-27 | Roche Diagnostics Gmbh | Device for separating and dispensing plasma |
TWI333545B (en) * | 2003-04-02 | 2010-11-21 | Cholestech Corp | Adhered membranes retaining porosity and biological activity |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7875293B2 (en) * | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
WO2007120442A2 (en) | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP1711790B1 (en) | 2003-12-05 | 2010-09-08 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20050130177A1 (en) | 2003-12-12 | 2005-06-16 | 3M Innovative Properties Company | Variable valve apparatus and methods |
US7322254B2 (en) * | 2003-12-12 | 2008-01-29 | 3M Innovative Properties Company | Variable valve apparatus and methods |
US20050142570A1 (en) * | 2003-12-24 | 2005-06-30 | 3M Innovative Properties Company | Methods for nucleic acid isolation and kits using a microfluidic device and sedimenting reagent |
US7727710B2 (en) * | 2003-12-24 | 2010-06-01 | 3M Innovative Properties Company | Materials, methods, and kits for reducing nonspecific binding of molecules to a surface |
US7939249B2 (en) * | 2003-12-24 | 2011-05-10 | 3M Innovative Properties Company | Methods for nucleic acid isolation and kits using a microfluidic device and concentration step |
US20050142571A1 (en) * | 2003-12-24 | 2005-06-30 | 3M Innovative Properties Company | Methods for nucleic acid isolation and kits using solid phase material |
WO2005079257A2 (en) * | 2004-02-12 | 2005-09-01 | Dexcom, Inc. | Biointerface with macro- and micro- architecture |
US20050245799A1 (en) * | 2004-05-03 | 2005-11-03 | Dexcom, Inc. | Implantable analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20080242961A1 (en) * | 2004-07-13 | 2008-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
US7763210B2 (en) | 2005-07-05 | 2010-07-27 | 3M Innovative Properties Company | Compliant microfluidic sample processing disks |
US7323660B2 (en) * | 2005-07-05 | 2008-01-29 | 3M Innovative Properties Company | Modular sample processing apparatus kits and modules |
US7754474B2 (en) | 2005-07-05 | 2010-07-13 | 3M Innovative Properties Company | Sample processing device compression systems and methods |
CA2622295C (en) | 2005-09-12 | 2019-01-15 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
US20070224701A1 (en) * | 2006-02-16 | 2007-09-27 | Becton, Dickinson And Company | Combination vertical and lateral flow immunoassay device |
US9119577B2 (en) | 2006-03-01 | 2015-09-01 | Home Access Health Corporation | Specimen collection device |
SE530596C2 (en) * | 2006-10-13 | 2008-07-15 | Mathias Karlsson | Method of determining oxygen deficiency in blood from the scalp during labor |
US20080166818A1 (en) * | 2007-01-08 | 2008-07-10 | Saliva Diagnostic Systems Inc. | Integrated Sample Collector And Tester For Bodily Fluid |
WO2008086019A1 (en) * | 2007-01-09 | 2008-07-17 | Cholestech Corporation | Device and method for measuring ldl-associated cholesterol |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
EP2060315A3 (en) | 2007-11-15 | 2009-08-12 | DSMIP Assets B.V. | High performance membrane |
US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
USD667561S1 (en) | 2009-11-13 | 2012-09-18 | 3M Innovative Properties Company | Sample processing disk cover |
USD638550S1 (en) | 2009-11-13 | 2011-05-24 | 3M Innovative Properties Company | Sample processing disk cover |
USD638951S1 (en) | 2009-11-13 | 2011-05-31 | 3M Innovative Properties Company | Sample processing disk cover |
US8834792B2 (en) | 2009-11-13 | 2014-09-16 | 3M Innovative Properties Company | Systems for processing sample processing devices |
EP2375249B1 (en) * | 2010-04-09 | 2019-12-25 | F. Hoffmann-La Roche AG | Devices and process for separating plasma from a blood sample |
WO2012158990A1 (en) | 2011-05-18 | 2012-11-22 | 3M Innovative Properties Company | Systems and methods for volumetric metering on a sample processing device |
ES2870874T3 (en) | 2011-05-18 | 2021-10-27 | Diasorin S P A | Systems and methods for detecting the presence of a selected volume of material in a sample processing device |
WO2012158988A1 (en) | 2011-05-18 | 2012-11-22 | 3M Innovative Properties Company | Systems and methods for valving on a sample processing device |
DE102013226220A1 (en) * | 2012-12-21 | 2014-06-26 | Robert Bosch Gmbh | Induction hand tool battery device |
USD865992S1 (en) * | 2015-11-02 | 2019-11-05 | Jon A. Petty | Fluid test strip |
CA3097508A1 (en) | 2017-04-17 | 2018-10-25 | Dignity Health | Salivary urea nitrogen rapid detection |
US10948403B2 (en) * | 2017-10-06 | 2021-03-16 | Bio-Rad Laboratories, Inc. | Protein quantitation device |
CN108507814A (en) * | 2018-03-06 | 2018-09-07 | 冯悦然 | A kind of sampling and transportation resources of clast |
JP7177454B2 (en) * | 2020-04-23 | 2022-11-24 | 株式会社ユカシカド | Test strips for measuring minerals in urine |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3092465A (en) * | 1960-03-25 | 1963-06-04 | Miles Lab | Diagnostic test device for blood sugar |
US3368872A (en) * | 1964-08-31 | 1968-02-13 | Scientific Industries | Automatic chemical analyzer |
US3983005A (en) * | 1974-03-25 | 1976-09-28 | Eastman Kodak Company | Integral element for the analysis of cholesterol |
US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
US4066403A (en) * | 1975-06-20 | 1978-01-03 | Eastman Kodak Company | Multilayer analytical element |
US4144306A (en) * | 1977-01-14 | 1979-03-13 | Eastman Kodak Company | Element for analysis of liquids |
US4223089A (en) * | 1978-05-17 | 1980-09-16 | Boehringer Mannheim Gmbh | Process and diagnostic device for the determination of ammonia and of substrates which react with the formation of ammonia |
US4292272A (en) * | 1979-06-08 | 1981-09-29 | Fuji Photo Film Co., Ltd. | Multilayer analysis sheet for analyzing liquid samples |
US4476222A (en) * | 1982-08-02 | 1984-10-09 | Eiken Kagaku Kabushiki Kaisha | Test piece for quantitative analysis of substances in body fluids |
US4477575A (en) * | 1980-08-05 | 1984-10-16 | Boehringer Mannheim Gmbh | Process and composition for separating plasma or serum from whole blood |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS603842B2 (en) * | 1976-09-03 | 1985-01-31 | 住友電気工業株式会社 | Asymmetric pore diameter thin film material and its manufacturing method |
JPS56159128A (en) * | 1980-05-15 | 1981-12-08 | Asahi Chem Ind Co Ltd | Thermoplastic resin porous film and production thereof |
JPS5924732A (en) * | 1982-08-02 | 1984-02-08 | Mitsubishi Rayon Co Ltd | Hydrophilic porous membrane and its production |
US4501793A (en) * | 1983-06-17 | 1985-02-26 | Celanese Corporation | Surfactant treated polyolefinic microporous materials capable of multiple re-wetting with aqueous solutions |
US4525374A (en) * | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
-
1985
- 1985-10-18 US US06/788,793 patent/US4839296A/en not_active Expired - Lifetime
-
1986
- 1986-10-16 CA CA000520622A patent/CA1296976C/en not_active Expired - Fee Related
- 1986-10-16 AT AT86906634T patent/ATE80564T1/en not_active IP Right Cessation
- 1986-10-16 EP EP86906634A patent/EP0248037B1/en not_active Expired - Lifetime
- 1986-10-16 WO PCT/US1986/002192 patent/WO1987002267A1/en active IP Right Grant
- 1986-10-16 AU AU65240/86A patent/AU594389B2/en not_active Ceased
- 1986-10-16 DE DE8686906634T patent/DE3686767T2/en not_active Expired - Fee Related
- 1986-10-16 JP JP61505556A patent/JPH0743374B2/en not_active Expired - Fee Related
-
1987
- 1987-06-17 RU SU874203103A patent/RU1838782C/en active
- 1987-06-18 DK DK311187A patent/DK166171C/en not_active IP Right Cessation
- 1987-06-18 NO NO872565A patent/NO872565L/en unknown
- 1987-06-18 FI FI872741A patent/FI89108C/en not_active IP Right Cessation
-
1989
- 1989-06-12 US US07/364,893 patent/US5130231A/en not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3092465A (en) * | 1960-03-25 | 1963-06-04 | Miles Lab | Diagnostic test device for blood sugar |
US3368872A (en) * | 1964-08-31 | 1968-02-13 | Scientific Industries | Automatic chemical analyzer |
US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
US3983005A (en) * | 1974-03-25 | 1976-09-28 | Eastman Kodak Company | Integral element for the analysis of cholesterol |
US4066403A (en) * | 1975-06-20 | 1978-01-03 | Eastman Kodak Company | Multilayer analytical element |
US4144306A (en) * | 1977-01-14 | 1979-03-13 | Eastman Kodak Company | Element for analysis of liquids |
US4223089A (en) * | 1978-05-17 | 1980-09-16 | Boehringer Mannheim Gmbh | Process and diagnostic device for the determination of ammonia and of substrates which react with the formation of ammonia |
US4292272A (en) * | 1979-06-08 | 1981-09-29 | Fuji Photo Film Co., Ltd. | Multilayer analysis sheet for analyzing liquid samples |
US4477575A (en) * | 1980-08-05 | 1984-10-16 | Boehringer Mannheim Gmbh | Process and composition for separating plasma or serum from whole blood |
US4477575B1 (en) * | 1980-08-05 | 1992-04-21 | Boehringer Mannheim Gmbh | |
US4476222A (en) * | 1982-08-02 | 1984-10-09 | Eiken Kagaku Kabushiki Kaisha | Test piece for quantitative analysis of substances in body fluids |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0436897A3 (en) * | 1990-01-12 | 1992-03-11 | Miles Inc. | Device and method of separating and assaying whole blood |
EP0436897A2 (en) * | 1990-01-12 | 1991-07-17 | Miles Inc. | Device and method of separating and assaying whole blood |
US6962819B1 (en) | 1991-07-22 | 2005-11-08 | Fuji Photo Film Co., Ltd. | Method of measuring analyte using dry analytical element |
EP0524596A1 (en) * | 1991-07-22 | 1993-01-27 | Fuji Photo Film Co., Ltd. | Method of measuring analyte using dry analytical element |
EP0535485A1 (en) * | 1991-10-03 | 1993-04-07 | Bayer Corporation | Improved device and method of separating and assaying whole blood |
US5558834A (en) * | 1991-10-03 | 1996-09-24 | Bayer Corporation | Device and method of seperating and assaying whole blood |
GB2285951A (en) * | 1994-01-21 | 1995-08-02 | Robert Gittins | Semi-permeable membrane |
EP0785012A1 (en) | 1996-01-19 | 1997-07-23 | Fuji Photo Film Co., Ltd. | Blood filter unit |
EP0785430A1 (en) | 1996-01-19 | 1997-07-23 | Fuji Photo Film Co., Ltd. | Separation of plasma or serum sample from whole blood |
WO1998001753A1 (en) * | 1996-07-05 | 1998-01-15 | Amrad Operations Pty. Limited | Blood separation module |
US5996811A (en) * | 1997-02-13 | 1999-12-07 | Fuji Photo Film Co. Ltd. | Plasma collecting device |
ITMI20101730A1 (en) * | 2010-09-23 | 2012-03-24 | Fond Italiana Fegato Onlus | "POINT OF CARE" TYPE SYSTEM OF MEASURING TOTAL BILIRUBIN IN PLASMA, PARTICULARLY OF BABIES |
WO2012038930A1 (en) * | 2010-09-23 | 2012-03-29 | Fondazione Italiana Fegato-Onlus | System of the "point of care" type for measuring total plasma bilirubin especially of neonates |
US11697279B2 (en) | 2013-06-10 | 2023-07-11 | Roche Diagnostics Operations, Inc. | Method and device for producing a test element |
US11278219B2 (en) * | 2017-09-29 | 2022-03-22 | W. L. Gore & Associates, Inc. | Fluid handling detectors |
Also Published As
Publication number | Publication date |
---|---|
DE3686767T2 (en) | 1993-02-11 |
NO872565D0 (en) | 1987-06-18 |
FI872741A (en) | 1987-06-18 |
US5130231A (en) | 1992-07-14 |
CA1296976C (en) | 1992-03-10 |
NO872565L (en) | 1987-08-18 |
AU594389B2 (en) | 1990-03-08 |
FI872741A0 (en) | 1987-06-18 |
DK311187A (en) | 1987-06-18 |
ATE80564T1 (en) | 1992-10-15 |
FI89108C (en) | 1993-08-10 |
FI89108B (en) | 1993-04-30 |
EP0248037B1 (en) | 1992-09-16 |
DE3686767D1 (en) | 1992-10-22 |
DK166171C (en) | 1993-08-09 |
JPS63501594A (en) | 1988-06-16 |
US4839296A (en) | 1989-06-13 |
RU1838782C (en) | 1993-08-30 |
DK311187D0 (en) | 1987-06-18 |
AU6524086A (en) | 1987-05-05 |
JPH0743374B2 (en) | 1995-05-15 |
EP0248037A4 (en) | 1989-07-11 |
DK166171B (en) | 1993-03-15 |
EP0248037A1 (en) | 1987-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4839296A (en) | Blood plasma test method | |
EP0359831B1 (en) | Biosensor and process for its production | |
US6485923B1 (en) | Reagent test strip for analyte determination having hemolyzing agent | |
US5229282A (en) | Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system | |
US4356149A (en) | Multi-layer chemical analytical materials | |
EP0654659B1 (en) | Defined volume test device | |
US4587100A (en) | Multilayer analytical element for the detection of hydrogen peroxide | |
JP2001518622A (en) | Analyzer using capillary reagent carrier | |
WO1998020348A1 (en) | Opaque reaction matrix for the analysis of whole blood | |
JP2002510392A (en) | Analyte measuring device in body fluid | |
US3418083A (en) | Hydrophobic test strip for analyzing whole blood | |
JPH0317479B2 (en) | ||
JPS6190050A (en) | Production of chip for biosensor | |
JPH0721455B2 (en) | Tools and Methods for Analyzing Specific Components in Liquid Samples | |
JPH03130662A (en) | Device and method for separating plasma from blood and method of measuring analytic object in blood | |
JPS5926061A (en) | Test piece for determining component in bodily fluid | |
JPH0688816A (en) | Asymmetrical sandwich film system as diagnostic test device | |
JPH0772145A (en) | Asymmetrical porous film | |
JPH05203655A (en) | Device and method for biological analysis containing particle separation system | |
JPH05260994A (en) | Detection of analyte in saliva using peroxide-peroxidase test system | |
JPH0521013Y2 (en) | ||
JPS63163164A (en) | Multi-layer analysis element | |
JPH0521014Y2 (en) | ||
KR850001297B1 (en) | Process for preparing blood-sugar measuring paper | |
JPH0545189B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU DK FI JP KR SU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986906634 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 872741 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1986906634 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1986906634 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 872741 Country of ref document: FI |